{{DISPLAYTITLE:Indium (<sup>111</sup>In) imciromab}}
{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 458272134
| drug_name = Indium (<sup>111</sup>In) imciromab
<!-- Monoclonal antibody data -->
| type = mab
| mab_type = fab
| source = o
| target = cardiac [[myosin]]
<!-- Clinical data -->
| tradename = Myoscint
| pregnancy_AU =  
| pregnancy_US =  
| pregnancy_category =  
| legal_AU =  
| legal_CA =  
| legal_UK =  
| legal_US =  
| legal_status = withdrawn
| routes_of_administration =  
<!-- Pharmacokinetic data -->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  
<!-- Identifiers -->
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = none
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 126132-83-0
| CAS_supplemental = (imciromab)
| ATC_prefix = V09
| ATC_suffix = GX02
| PubChem =  
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
<!-- Chemical data -->
| chemical_formula =  
| molecular_weight =  
}}

'''Indium (<sup>111</sup>In) imciromab''' (trade name '''Myoscint''') is a [[mouse]] [[monoclonal antibody]] labelled with the [[radioisotope]] [[Indium-111]].<ref>[http://apps.who.int/medicinedocs/documents/h5791e/h5791e.pdf WHO Drug Information]</ref> It was used for [[cardiac]] imaging, but withdrawn in 1993.<ref>[http://www.diagnosticimaging.com/news/display/article/113619/1236557?verify=0 DiagnosticImaging.com: Centocor withdraws imaging agent applications]</ref>

==See also==
*[[Nuclear medicine]]

==References==
{{reflist}}

{{Radiopharmaceuticals}}
{{Monoclonals for bone, musculoskeletal, circulatory, and neurologic systems}}

[[Category:Radiopharmaceuticals]]


{{monoclonal-antibody-stub}}